CCRC FINAL PAPER 2026 QUESTIONS WITH
ANSWERS GRADED A+
◉ E6(R1) 1. Answer: Glossary of terms
◉ Adverse Event (AE). Answer: Any untoward medical occurrence in a
patient or clinical investigation subject administered a pharmaceutical
product and which does not necessarily have a causal relationship with
this treatment--any unfavorable and unintended sign , symptom, or
disease temporally associated with the use of a medicinal product,
whether or not related to the medicinal product
◉ Applicable Regulatory Requirements. Answer: Any law(s) and
regulation(s) addressing the conduct of clinical trials of investigational
products
◉ Institutional Review Board Approval. Answer: The affirmative
decision of the IRB that the clinical trial has been reviewed and may be
conducted at the institution site within the constraints set forth by the
IRB, the institution, Good Clinical Practice (GCP), and the applicable
regulatory requirements
◉ Audit. Answer: A systematic and independent examination of trial
related activities and documents to determine whether the evaluated trial
,related activities were conducted, and the data were recorded, analyzed
and accurately reported according to the protocol, sponsor's standard
operating procedures, (SOPs), Good Clinical Practice (GCP), and the
applicable regulatory requirement(s)
◉ Audit Certificate. Answer: A declaration of confirmation by the
auditor that an audit has taken place
◉ Audit Report. Answer: A written evaluation by the sponsor's auditor
of the results of the audit
◉ Audit Trail. Answer: Documentation that allows reconstruction of the
course of events
◉ Blinding/Masking. Answer: A procedure in which one or more parties
to the trial are kept unaware of the treatment assignment(s).
◉ Case Report Form (CRF). Answer: A printed, optical, or electronic
document designed to record all of the protocol required information to
be reported to the sponsor on each trial subject.
◉ Clinical Trial/Study. Answer: Any investigation in human subjects
intended to discover or verify the clinical, pharmacological and/or other
pharmacodynamic effects of an investigational product(s), and/or to
identify any adverse reactions to an investigational product(s), and/or to
,study absorption, distribution, metabolism, and excretion of an
investigational product(s) with the object of ascertaining its safety and/or
efficacy
◉ Clinical Trial/Study Report. Answer: A written description of a
trial/study of any therapeutic, prophylactic, or diagnostic agent
conducted in human subjects, in which the clinical and statistical
description, presentations, and analyses are fully integrated into a single
report
◉ Comparator (Product). Answer: An investigational or marketed
product, or placebo, used as a reference in a clinical trial.
◉ Compliance to Trials. Answer: Adherence to all the trial-related
requirements, Good Clinical Practice (GCP) requirements, and the
applicable regulatory requirements
◉ Confidentiality. Answer: Prevention of disclosure, to other than
authorized individuals, of a sponsor's proprietary information or of a
subject's identity.
◉ Contract. Answer: A written, dated, and signed agreement between
two or more involved parties that sets out any arrangements on
delegation and distribution of tasks and obligations and, if appropriate,
on financial matters.
, ◉ Coordinating Committee. Answer: A committee that a sponsor may
organize to coordinate the conduct of a multicenter trial.
◉ Coordinating Ivestigator. Answer: An investigator assigned the
responsibility for the coordination of investigators at different centers
participating in a multicenter trial
◉ Contract Research Organization (CRO). Answer: A person or an
organization (commercial, academic, or other) contracted by the sponsor
to perform one or more of a sponsor's trial-related duties and functions.
◉ Direct Access. Answer: Permission to examine, analyze, verify, and
reproduce any records and reports that are important to evaluation of a
clinical trial
◉ Documentation. Answer: All records, in any form that describe or
record the methods, conduct, and/or results of a trial, the factors
affecting a trial, and the actions taken
◉ Essential Documents. Answer: Documents which individually and
collectively permit evaluation of the conduct of a study and the quality
of the data produced
◉ Good Clinical Practice (GCP). Answer: A standard for the design,
conduct, performance, monitoring, auditing, recording, analyses, and
ANSWERS GRADED A+
◉ E6(R1) 1. Answer: Glossary of terms
◉ Adverse Event (AE). Answer: Any untoward medical occurrence in a
patient or clinical investigation subject administered a pharmaceutical
product and which does not necessarily have a causal relationship with
this treatment--any unfavorable and unintended sign , symptom, or
disease temporally associated with the use of a medicinal product,
whether or not related to the medicinal product
◉ Applicable Regulatory Requirements. Answer: Any law(s) and
regulation(s) addressing the conduct of clinical trials of investigational
products
◉ Institutional Review Board Approval. Answer: The affirmative
decision of the IRB that the clinical trial has been reviewed and may be
conducted at the institution site within the constraints set forth by the
IRB, the institution, Good Clinical Practice (GCP), and the applicable
regulatory requirements
◉ Audit. Answer: A systematic and independent examination of trial
related activities and documents to determine whether the evaluated trial
,related activities were conducted, and the data were recorded, analyzed
and accurately reported according to the protocol, sponsor's standard
operating procedures, (SOPs), Good Clinical Practice (GCP), and the
applicable regulatory requirement(s)
◉ Audit Certificate. Answer: A declaration of confirmation by the
auditor that an audit has taken place
◉ Audit Report. Answer: A written evaluation by the sponsor's auditor
of the results of the audit
◉ Audit Trail. Answer: Documentation that allows reconstruction of the
course of events
◉ Blinding/Masking. Answer: A procedure in which one or more parties
to the trial are kept unaware of the treatment assignment(s).
◉ Case Report Form (CRF). Answer: A printed, optical, or electronic
document designed to record all of the protocol required information to
be reported to the sponsor on each trial subject.
◉ Clinical Trial/Study. Answer: Any investigation in human subjects
intended to discover or verify the clinical, pharmacological and/or other
pharmacodynamic effects of an investigational product(s), and/or to
identify any adverse reactions to an investigational product(s), and/or to
,study absorption, distribution, metabolism, and excretion of an
investigational product(s) with the object of ascertaining its safety and/or
efficacy
◉ Clinical Trial/Study Report. Answer: A written description of a
trial/study of any therapeutic, prophylactic, or diagnostic agent
conducted in human subjects, in which the clinical and statistical
description, presentations, and analyses are fully integrated into a single
report
◉ Comparator (Product). Answer: An investigational or marketed
product, or placebo, used as a reference in a clinical trial.
◉ Compliance to Trials. Answer: Adherence to all the trial-related
requirements, Good Clinical Practice (GCP) requirements, and the
applicable regulatory requirements
◉ Confidentiality. Answer: Prevention of disclosure, to other than
authorized individuals, of a sponsor's proprietary information or of a
subject's identity.
◉ Contract. Answer: A written, dated, and signed agreement between
two or more involved parties that sets out any arrangements on
delegation and distribution of tasks and obligations and, if appropriate,
on financial matters.
, ◉ Coordinating Committee. Answer: A committee that a sponsor may
organize to coordinate the conduct of a multicenter trial.
◉ Coordinating Ivestigator. Answer: An investigator assigned the
responsibility for the coordination of investigators at different centers
participating in a multicenter trial
◉ Contract Research Organization (CRO). Answer: A person or an
organization (commercial, academic, or other) contracted by the sponsor
to perform one or more of a sponsor's trial-related duties and functions.
◉ Direct Access. Answer: Permission to examine, analyze, verify, and
reproduce any records and reports that are important to evaluation of a
clinical trial
◉ Documentation. Answer: All records, in any form that describe or
record the methods, conduct, and/or results of a trial, the factors
affecting a trial, and the actions taken
◉ Essential Documents. Answer: Documents which individually and
collectively permit evaluation of the conduct of a study and the quality
of the data produced
◉ Good Clinical Practice (GCP). Answer: A standard for the design,
conduct, performance, monitoring, auditing, recording, analyses, and
